GlassScriptPhysician profile
Nhi Nguyen
NPI 1285293456
$3,214.04
in general payments reported to CMS, 2019-2025
19 companies · $578 in 2025
The $578 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $145 · 2021: $446 · 2022: $358 · 2023: $446 · 2024: $889 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,678 · Entertainment: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.01 |
| Entertainment | $235.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $642.30 | 2021-2025 | Cequa |
| Optos, INC. | $340.27 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $268.42 | 2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $225.17 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $200.19 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $195.47 | 2019-2023 | |
| Glaukos Corporation | $176.37 | 2022-2025 | Idosetr |
| Allergan, INC. | $148.11 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $145.66 | 2021 | |
| Bausch & Lomb Americas INC. | $138.81 | 2024-2025 | Xiidra, Miebo |
| Oyster Point Pharma, INC. | $129.57 | 2022-2023 | Tyrvaya |
| Carl Zeiss Meditec USA, INC. | $123.41 | 2023 | |
| Lkc Technologies, INC. | $119.20 | 2023 | |
| Biotissue Holdings INC. | $103.83 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $90.38 | 2021-2023 | Acuvue |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $60.95 | 2025 | Tryptyr |
| Harrow Eye, LLC | $54.70 | 2024 | Vevye |
| Abbvie INC. | $26.17 | 2022 | |
| Pfizer INC. | $25.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nhi Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.